# Nlight, Inc.: financial statements, quarterly

LASR · Nasdaq · CIK 1124796 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lasr.md) · [Financials](/companies/lasr/financials.md) · [Filings](/companies/lasr/filings.md) · [Insiders](/companies/lasr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lasr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [50.6](/filings/0001124796-24-000129.md) | [51.9 d](/filings/0001124796-26-000012.md) | [44.5](/filings/0001124796-25-000053.md) | [50.5](/filings/0001124796-25-000120.md) | [56.1](/filings/0001124796-25-000154.md) | [47.4 d](/filings/0001124796-26-000012.md) | [51.7](/filings/0001124796-26-000028.md) | [61.7](/filings/0001124796-26-000038.md) | [66.7](/filings/0001124796-25-000154.md) | [81.2 d](/filings/0001124796-26-000012.md) | [80.2](/filings/0001124796-26-000028.md) | [82.6](/filings/0001124796-26-000038.md) |
| Cost of revenue | $m | [40.7](/filings/0001124796-24-000129.md) | [42.1 d](/filings/0001124796-26-000012.md) | [37.0](/filings/0001124796-25-000053.md) | [38.7](/filings/0001124796-25-000120.md) | [43.6](/filings/0001124796-25-000154.md) | [46.3 d](/filings/0001124796-26-000012.md) | [37.9](/filings/0001124796-26-000028.md) | [43.3](/filings/0001124796-26-000038.md) | [46.0](/filings/0001124796-25-000154.md) | [56.2 d](/filings/0001124796-26-000012.md) | [53.7](/filings/0001124796-26-000028.md) | [56.9](/filings/0001124796-26-000038.md) |
| Gross profit | $m | [9.9](/filings/0001124796-24-000129.md) | [9.8 d](/filings/0001124796-26-000012.md) | [7.5](/filings/0001124796-25-000053.md) | [11.9](/filings/0001124796-25-000120.md) | [12.6](/filings/0001124796-25-000154.md) | [1.1 d](/filings/0001124796-26-000012.md) | [13.8](/filings/0001124796-26-000028.md) | [18.5](/filings/0001124796-26-000038.md) | [20.8](/filings/0001124796-25-000154.md) | [25.0 d](/filings/0001124796-26-000012.md) | [26.5](/filings/0001124796-26-000028.md) | [25.7](/filings/0001124796-26-000038.md) |
| Research and development | $m | [10.7](/filings/0001124796-24-000129.md) | [12.1 d](/filings/0001124796-26-000012.md) | [10.7](/filings/0001124796-25-000053.md) | [11.7](/filings/0001124796-25-000120.md) | [11.3](/filings/0001124796-25-000154.md) | [11.4 d](/filings/0001124796-26-000012.md) | [11.4](/filings/0001124796-26-000028.md) | [11.0](/filings/0001124796-26-000038.md) | [11.5](/filings/0001124796-25-000154.md) | [14.1 d](/filings/0001124796-26-000012.md) | [11.8](/filings/0001124796-26-000028.md) | [13.1](/filings/0001124796-26-000038.md) |
| Selling, general and administrative | $m | [11.7](/filings/0001124796-24-000129.md) | [11.2 d](/filings/0001124796-26-000012.md) | [11.5](/filings/0001124796-25-000053.md) | [12.8](/filings/0001124796-25-000120.md) | [13.0](/filings/0001124796-25-000154.md) | [11.9 d](/filings/0001124796-26-000012.md) | [12.0](/filings/0001124796-26-000028.md) | [11.7](/filings/0001124796-26-000038.md) | [14.8](/filings/0001124796-25-000154.md) | [15.7 d](/filings/0001124796-26-000012.md) | [15.1](/filings/0001124796-26-000028.md) | [16.2](/filings/0001124796-26-000038.md) |
| Operating income | $m | [(12.5)](/filings/0001124796-24-000129.md) | [(14.3) d](/filings/0001124796-26-000012.md) | [(14.7)](/filings/0001124796-25-000053.md) | [(12.7)](/filings/0001124796-25-000120.md) | [(11.8)](/filings/0001124796-25-000154.md) | [(26.4) d](/filings/0001124796-26-000012.md) | [(9.6)](/filings/0001124796-26-000028.md) | [(4.2)](/filings/0001124796-26-000038.md) | [(7.3)](/filings/0001124796-25-000154.md) | [(5.4) d](/filings/0001124796-26-000012.md) | [(0.7)](/filings/0001124796-26-000028.md) | [(3.6)](/filings/0001124796-26-000038.md) |
| Interest expense | $m | not reported | not reported | not reported | [0.0](/filings/0001124796-25-000120.md) | [0.0](/filings/0001124796-25-000154.md) | [0.0 d](/filings/0001124796-26-000012.md) | [0.0](/filings/0001124796-26-000028.md) | [0.4](/filings/0001124796-26-000038.md) | [0.3](/filings/0001124796-25-000154.md) | [0.3 d](/filings/0001124796-26-000012.md) | [0.3](/filings/0001124796-26-000028.md) | [0.2](/filings/0001124796-26-000038.md) |
| Income tax | $m | [0.2](/filings/0001124796-24-000129.md) | [0.0 d](/filings/0001124796-26-000012.md) | [0.1](/filings/0001124796-25-000053.md) | [0.1](/filings/0001124796-25-000120.md) | [0.3](/filings/0001124796-25-000154.md) | [(0.6) d](/filings/0001124796-26-000012.md) | [0.1](/filings/0001124796-26-000028.md) | [0.0](/filings/0001124796-26-000038.md) | [0.3](/filings/0001124796-25-000154.md) | [0.3 d](/filings/0001124796-26-000012.md) | [0.1](/filings/0001124796-26-000028.md) | [0.1](/filings/0001124796-26-000038.md) |
| Net income | $m | [(11.9)](/filings/0001124796-24-000129.md) | [(13.2) d](/filings/0001124796-26-000012.md) | [(13.8)](/filings/0001124796-25-000053.md) | [(11.7)](/filings/0001124796-25-000120.md) | [(10.3)](/filings/0001124796-25-000154.md) | [(25.0) d](/filings/0001124796-26-000012.md) | [(8.1)](/filings/0001124796-26-000028.md) | [(3.6)](/filings/0001124796-26-000038.md) | [(6.9)](/filings/0001124796-25-000154.md) | [(4.9) d](/filings/0001124796-26-000012.md) | [0.6](/filings/0001124796-26-000028.md) | [(1.3)](/filings/0001124796-26-000038.md) |
| Diluted EPS | $ per share | [(0.26)](/filings/0001124796-24-000129.md) | not reported | [(0.29)](/filings/0001124796-25-000053.md) | [(0.25)](/filings/0001124796-25-000120.md) | [(0.21)](/filings/0001124796-25-000154.md) | not reported | [(0.16)](/filings/0001124796-26-000028.md) | [(0.07)](/filings/0001124796-26-000038.md) | [(0.14)](/filings/0001124796-25-000154.md) | not reported | [0.01](/filings/0001124796-26-000028.md) | [(0.02)](/filings/0001124796-26-000038.md) |
| Basic EPS | $ per share | [(0.26)](/filings/0001124796-24-000129.md) | not reported | [(0.29)](/filings/0001124796-25-000053.md) | [(0.25)](/filings/0001124796-25-000120.md) | [(0.21)](/filings/0001124796-25-000154.md) | not reported | [(0.16)](/filings/0001124796-26-000028.md) | [(0.07)](/filings/0001124796-26-000038.md) | [(0.14)](/filings/0001124796-25-000154.md) | not reported | [0.01](/filings/0001124796-26-000028.md) | [(0.02)](/filings/0001124796-26-000038.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [52.1](/filings/0001124796-24-000129.md) | [53.2](/filings/0001124796-26-000012.md) | [61.3](/filings/0001124796-25-000053.md) | [49.4](/filings/0001124796-25-000120.md) | [41.5](/filings/0001124796-25-000154.md) | [65.8](/filings/0001124796-26-000012.md) | [82.2](/filings/0001124796-26-000028.md) | [78.8](/filings/0001124796-26-000038.md) | [81.1](/filings/0001124796-25-000154.md) | [98.7](/filings/0001124796-26-000038.md) | [298](/filings/0001124796-26-000028.md) | [296](/filings/0001124796-26-000038.md) |
| Current assets | $m | [224](/filings/0001124796-23-000104.md) | [221](/filings/0001124796-25-000021.md) | [219](/filings/0001124796-24-000058.md) | [213](/filings/0001124796-24-000098.md) | [211](/filings/0001124796-24-000129.md) | [194](/filings/0001124796-26-000012.md) | [216](/filings/0001124796-25-000053.md) | [223](/filings/0001124796-25-000120.md) | [228](/filings/0001124796-25-000154.md) | [243](/filings/0001124796-26-000038.md) | [446](/filings/0001124796-26-000028.md) | [447](/filings/0001124796-26-000038.md) |
| Total assets | $m | [313](/filings/0001124796-23-000104.md) | [307](/filings/0001124796-25-000021.md) | [303](/filings/0001124796-24-000058.md) | [294](/filings/0001124796-24-000098.md) | [291](/filings/0001124796-24-000129.md) | [270](/filings/0001124796-26-000012.md) | [290](/filings/0001124796-25-000053.md) | [295](/filings/0001124796-25-000120.md) | [299](/filings/0001124796-25-000154.md) | [315](/filings/0001124796-26-000038.md) | [516](/filings/0001124796-26-000028.md) | [518](/filings/0001124796-26-000038.md) |
| Current liabilities | $m | [33.6](/filings/0001124796-23-000104.md) | [32.8](/filings/0001124796-25-000021.md) | [38.3](/filings/0001124796-24-000058.md) | [34.8](/filings/0001124796-24-000098.md) | [36.1](/filings/0001124796-24-000129.md) | [34.2](/filings/0001124796-26-000012.md) | [37.2](/filings/0001124796-25-000053.md) | [39.6](/filings/0001124796-25-000120.md) | [40.5](/filings/0001124796-25-000154.md) | [64.2](/filings/0001124796-26-000038.md) | [63.0](/filings/0001124796-26-000028.md) | [54.7](/filings/0001124796-26-000038.md) |
| Total liabilities | $m | [53.3](/filings/0001124796-23-000104.md) | [52.4](/filings/0001124796-25-000021.md) | [58.5](/filings/0001124796-24-000058.md) | [54.8](/filings/0001124796-24-000098.md) | [56.0](/filings/0001124796-24-000129.md) | [53.8](/filings/0001124796-26-000012.md) | [77.2](/filings/0001124796-25-000053.md) | [79.3](/filings/0001124796-25-000120.md) | [80.2](/filings/0001124796-25-000154.md) | [88.5](/filings/0001124796-26-000038.md) | [86.5](/filings/0001124796-26-000028.md) | [77.7](/filings/0001124796-26-000038.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [260](/filings/0001124796-24-000129.md) | [254](/filings/0001124796-26-000012.md) | [244](/filings/0001124796-25-000120.md) | [240](/filings/0001124796-25-000154.md) | [235](/filings/0001124796-25-000154.md) | [216](/filings/0001124796-26-000038.md) | [213](/filings/0001124796-26-000038.md) | [216](/filings/0001124796-26-000038.md) | [218](/filings/0001124796-25-000154.md) | [227](/filings/0001124796-26-000038.md) | [429](/filings/0001124796-26-000038.md) | [440](/filings/0001124796-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.2 d](/filings/0001124796-24-000129.md) | [0.4 d](/filings/0001124796-26-000012.md) | [11.4](/filings/0001124796-25-000053.md) | [(4.2) d](/filings/0001124796-25-000120.md) | [(5.6) d](/filings/0001124796-25-000154.md) | [(3.9) d](/filings/0001124796-26-000012.md) | [(0.0)](/filings/0001124796-26-000028.md) | [(1.4) d](/filings/0001124796-26-000038.md) | [5.2 d](/filings/0001124796-25-000154.md) | [17.5 d](/filings/0001124796-26-000012.md) | [9.7](/filings/0001124796-26-000028.md) | [20.7 d](/filings/0001124796-26-000038.md) |
| Capital expenditure | $m | [2.7 d](/filings/0001124796-24-000129.md) | [1.0 d](/filings/0001124796-26-000012.md) | [1.6](/filings/0001124796-25-000053.md) | [2.1 d](/filings/0001124796-25-000120.md) | [1.6 d](/filings/0001124796-25-000154.md) | [2.6 d](/filings/0001124796-26-000012.md) | [2.3](/filings/0001124796-26-000028.md) | [2.4 d](/filings/0001124796-26-000038.md) | [2.8 d](/filings/0001124796-25-000154.md) | [1.6 d](/filings/0001124796-26-000012.md) | [2.1](/filings/0001124796-26-000028.md) | [4.9 d](/filings/0001124796-26-000038.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [44.8](/filings/0001124796-23-000104.md) | [45.7](/filings/0001124796-24-000058.md) | [45.7](/filings/0001124796-24-000098.md) | [46.4](/filings/0001124796-24-000129.md) | [47.2](/filings/0001124796-25-000053.md) | [47.7](/filings/0001124796-25-000120.md) | [48.1](/filings/0001124796-25-000154.md) | [49.1](/filings/0001124796-26-000028.md) | [49.6](/filings/0001124796-26-000038.md) | [50.3](/filings/0001124796-25-000154.md) | [60.0](/filings/0001124796-26-000028.md) | [57.0](/filings/0001124796-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 57,690,197 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001124796-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.